Resolution Therapeutics hails positive 4‑year MATCH data in liver cirrhosis

26th May 2026 Uncategorised 0

Findings strengthen rationale for EMERALD trial of engineered macrophage therapy RTX001

More: Resolution Therapeutics hails positive 4‑year MATCH data in liver cirrhosis
Source: News